China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Total Stockholders Equity : ¥20,533 Mil (As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is China Resourcesnjiu Medical & Pharmaceutical Co Total Stockholders Equity?

China Resourcesnjiu Medical & Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ¥20,533 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. China Resourcesnjiu Medical & Pharmaceutical Co's Book Value per Share for the quarter that ended in Sep. 2024 was ¥15.99. The ratio of a company's debt over equity can be used to measure how leveraged this company is. China Resourcesnjiu Medical & Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.13.

China Resourcesnjiu Medical & Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for China Resourcesnjiu Medical & Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resourcesnjiu Medical & Pharmaceutical Co Total Stockholders Equity Chart

China Resourcesnjiu Medical & Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

12,760.12

13,719.65

15,313.19

17,009.63

18,967.14

China Resourcesnjiu Medical & Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial															18,501.08	18,967.14	20,345.56	19,954.04	20,532.69

China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

China Resourcesnjiu Medical & Pharmaceutical Co's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(20532.689	-	0)	/	1284.33
	=	15.99

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

China Resourcesnjiu Medical & Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1225.563	+	1464.392)	/	20532.689
	=	0.13

China Resourcesnjiu Medical & Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of China Resourcesnjiu Medical & Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resourcesnjiu Medical & Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Sanjiu Medical & Pharmaceutical Co Ltd (SZSE:000999) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

High-Tech Park, Lake Street Mission Hills, Longhua District, Shenzhen, CHN, 518110

Website

http://www.999.com.cn

China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in the research and development, production and sale of pharmaceutical products, healthcare products, and medical appliances under the brand name 999, which includes OTC, antibiotic and raw material drug. The other brands under which the company offers its products are Lee King, Shunfeng, and Tianhe. The company's core business is located in OTC and Chinese medicine prescription drugs, OTC core products in the cold, gastrointestinal, skin, pediatric, cough and orthopedic drugs occupy a higher market share; prescription drug products in traditional Chinese medicine formula granules, cardiovascular and cerebrovascular, anti-tumor in the field of anti-infection and other areas.

Executives

Yang Zhan Ao	Executives
	Independent director
Li De Ming	Supervisors
Lin Xi Ping	Supervisors
Fang Ming	Director
Mai Yi	Executives

China Resourcesnjiu Medical & Pharmaceutical Co Headlines

No Headlines